These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11975450)

  • 21. Urine drug testing for social service agencies. A Canadian experience.
    Fraser AD
    Clin Lab Med; 1998 Dec; 18(4):705-11. PubMed ID: 9891609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposable microfluidic device with ultraviolet detection for highly resolved screening of illicit drugs.
    Qiang W; Zhai C; Lei J; Song C; Zhang D; Sheng J; Ju H
    Analyst; 2009 Sep; 134(9):1834-9. PubMed ID: 19684907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of glutaraldehyde (UrinAid) on detection of abused drugs in urine by immunoassay.
    Goldberger BA; Caplan YH
    Clin Chem; 1994 Aug; 40(8):1605-6. PubMed ID: 8045013
    [No Abstract]   [Full Text] [Related]  

  • 24. 'False-positive' and 'false-negative' test results in clinical urine drug testing.
    Reisfield GM; Goldberger BA; Bertholf RL
    Bioanalysis; 2009 Aug; 1(5):937-52. PubMed ID: 21083064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of the TRI Dipstick test for the detection of drugs of abuse in urine.
    Wallace JA; Blum K
    Subst Alcohol Actions Misuse; 1982; 3(1-2):129-32. PubMed ID: 6753193
    [No Abstract]   [Full Text] [Related]  

  • 26. Performance of AdultaCheck 4 test strips for the detection of adulteration at the point of collection of urine specimens used for drugs-of-abuse testing.
    King EJ
    J Anal Toxicol; 1999; 23(1):72. PubMed ID: 10022215
    [No Abstract]   [Full Text] [Related]  

  • 27. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choosing a drug test panel: concepts and considerations.
    Sagall R
    Occup Health Saf; 2005 Apr; 74(4):83-5. PubMed ID: 15915700
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.
    Moeller KE; Kissack JC; Atayee RS; Lee KC
    Mayo Clin Proc; 2017 May; 92(5):774-796. PubMed ID: 28325505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick".
    Biermann T; Schwarze B; Zedler B; Betz P
    Forensic Sci Int; 2004 Jun; 143(1):21-5. PubMed ID: 15177627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biosite receives clearance for the Triage TOX Drug Screen.
    Expert Rev Mol Diagn; 2002 Jan; 2(1):6. PubMed ID: 11963808
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapid spot tests for detecting the presence of adulterants in urine specimens submitted for drug testing.
    Dasgupta A; Wahed A; Wells A
    Am J Clin Pathol; 2002 Feb; 117(2):325-9. PubMed ID: 11863230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs of abuse in urine: some pitfalls in testing.
    Bosomworth MP
    Br J Biomed Sci; 1993 Jun; 50(2):150-5. PubMed ID: 8219920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary adulterants and drugs-of-abuse testing.
    Dasgupta A
    MLO Med Lab Obs; 2003 Feb; 35(2):26-8, 30-1. PubMed ID: 12624874
    [No Abstract]   [Full Text] [Related]  

  • 36. Urine drug screening in adolescents.
    Casavant MJ
    Pediatr Clin North Am; 2002 Apr; 49(2):317-27. PubMed ID: 11993285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the integrated E-Z split key(®) cup II for rapid detection of twelve drug classes in urine.
    Greene DN; Lehman CM; McMillin GA
    J Anal Toxicol; 2011 Jan; 35(1):46-53. PubMed ID: 21219703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid screening of drugs of abuse and their metabolites by gas chromatography/mass spectrometry: application to urinalysis.
    Strano-Rossi S; Molaioni F; Rossi F; Botrè F
    Rapid Commun Mass Spectrom; 2005; 19(11):1529-35. PubMed ID: 15880665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of urine adulterants on commercial drug abuse screening test strip results.
    Rajšić I; Javorac D; Tatović S; Repić A; Đukić-Ćosić D; Đorđević S; Lukić V; Bulat Z
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):87-93. PubMed ID: 32597134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and predictors of screen failures due to positive urine tests for alcohol, drugs of abuse, and cotinine among normal healthy research volunteers (NHRVs): analysis of data from 687 NHRVs screened at a large clinical pharmacology unit in the United States.
    Nada A; Baxter S; Loraas E; Somberg JC
    Am J Ther; 2008; 15(3):214-20. PubMed ID: 18496258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.